Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.06M | -36.35M | -32.60M | -29.63M | -25.74M |
| Total Depreciation and Amortization | 453.00K | 409.00K | 340.00K | 281.00K | 220.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.39M | 9.56M | 7.33M | 5.27M | 4.59M |
| Change in Net Operating Assets | -7.14M | -7.77M | -8.89M | -4.89M | -6.93M |
| Cash from Operations | -34.36M | -34.15M | -33.83M | -28.98M | -27.86M |
| Capital Expenditure | -556.00K | -432.00K | -638.00K | -642.00K | -630.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.33M | -44.00M | -24.81M | -24.84M | -684.00K |
| Cash from Investing | -45.89M | -44.44M | -25.45M | -25.48M | -1.31M |
| Total Debt Issued | -- | -- | -- | -- | -25.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.07M | 94.17M | 93.96M | 93.67M | 93.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 11.92M | 11.92M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -33.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -245.00K | -2.81M | -5.09M | -5.46M | -5.41M |
| Cash from Financing | 822.00K | 91.35M | 88.86M | 100.13M | 100.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.43M | 12.77M | 29.58M | 45.67M | 70.93M |